Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
90.28 CHF | +1.30% | +7.08% | +6.63% |
Apr. 24 | BMO Capital Adjusts Price Target on Novartis to $116 From $114, Maintains Market Perform Rating | MT |
Apr. 24 | Novartis Says New Malaria Drug Formulation Safe and Effective for Babies | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.63% | 199B | |
+23.48% | 562B | |
-5.45% | 358B | |
+20.85% | 322B | |
+8.88% | 297B | |
+13.25% | 219B | |
-10.10% | 196B | |
-8.93% | 149B | |
-5.12% | 146B | |
+2.33% | 117B |
- Stock Market
- Equities
- NOVN Stock
- News Novartis AG
- NOVARTIS AG : Buy rating from Jefferies